Pyxis Oncology, Inc.— Sankey Diagram

Annual mode · period ending 2025-12-31 · SEC EDGAR

FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$92M
↓-41.8% -$66Mvs FY2024
Total Liabilities
$38M
↑+4.6% +$2Mvs FY2024
Equity
$53M
↓-55.8% -$67Mvs FY2024
Cash
$15M
↓-20.8% -$4Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the annual mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2025FY2024
Total Assets$92M$157M
Current Assets$72M$132M
Cash$15M$19M
ST Investments$51M$107M
Receivables$0$0
Inventory$0$0
Other Current$5M$6M
Non-Current Assets$19M$25M
PPE$8M$10M
Goodwill$0$0
Intangibles$0$3M
Investments$0$0
Other Non-Current$11M$12M
Total Liab+Eq$92M$157M
Current Liab.$21M$18M
Accounts Payable$11M$5M
Short-Term Debt$0$0
Deferred Revenue$0$0
Other CL$10M$13M
Non-Current Liab.$17M$19M
Long-Term Debt$0$0
Other LT Liab.$17M$19M
Equity$53M$121M
Retained Earnings$443M$364M
Other Equity$0$0

QuarterCharts · SEC EDGAR data · PYXS · Comparing FY2025 vs FY2024